1312815-35-2 Usage
Uses
Used in Pharmaceutical Industry:
2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid is used as a key intermediate in the synthesis of thiamine analogs for the treatment of thiamine deficiency and related conditions. Its role in the development of drugs is crucial due to its structural similarity to thiamine, allowing for the creation of compounds that can address specific deficiencies or conditions effectively.
Used in Antioxidant Applications:
In the field of medicine and biotechnology, 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid is utilized for its potential antioxidant properties. It can be employed in formulations designed to combat oxidative stress and related diseases, providing a protective effect against cellular damage caused by reactive oxygen species.
Used in Antimicrobial Applications:
2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid is also used as an antimicrobial agent, particularly in the development of new antibiotics or antifungal agents. Its potential to inhibit the growth of microorganisms makes it a candidate for use in pharmaceuticals aimed at treating infections caused by various pathogens.
Used in Research and Development:
2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid is used as a research tool in the discovery and development of new drugs and pharmaceuticals. Its unique structure allows scientists to explore its interactions with biological systems, potentially leading to the identification of new therapeutic targets and the development of innovative treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 1312815-35-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,8,1 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1312815-35:
(9*1)+(8*3)+(7*1)+(6*2)+(5*8)+(4*1)+(3*5)+(2*3)+(1*5)=122
122 % 10 = 2
So 1312815-35-2 is a valid CAS Registry Number.
1312815-35-2Relevant academic research and scientific papers
PROCESSES FOR THE PREPARATION OF FEBUXOSTAT AND SALTS THEREOF
-
Page/Page column 29, (2011/07/07)
There is provided a process for preparing febuxostat of formula (I) or a pharmaceutically acceptable salt thereof, the process comprising: condensing a compound of formula (A) with a compound of formula (B) to form an ester of febuxostat; hydrolyzing the ester of febuxostat to febuxostat, and optionally converting the febuxostat to a pharmaceutically acceptable salt thereof, wherein: R' is an activating group selected from boronic acid or lithium; R is selected from optionally substituted C1-4 alkyl or optionally substituted aryl; L is a leaving group selected from diazo, halo, -OSO2R", -OCOR" or -O-Si(R")3; and R" is selected from optionally substituted C1-4 alkyl or optionally substituted aryl.
